ALAN LIEN: Open Payments
NPI 1467950493 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,474 in 174 payments from 17 companies in 2025. Trend: 2023 $1,386 · 2024 $4,005 · 2025 $3,474
Food & beverage: $3,399Education: $75
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 27 | $540 |
| Janssen Scientific Affairs, LLC | 4 | $358 |
| ABBVIE INC. | 19 | $337 |
| Arcutis Biotherapeutics, Inc. | 22 | $312 |
| Amgen Inc. | 13 | $299 |
| Janssen Biotech, Inc. | 19 | $290 |
| UCB, Inc. | 9 | $186 |
| LEO Pharma Inc. | 8 | $164 |
| Verrica Pharmaceuticals Inc. | 21 | $155 |
| GENZYME CORPORATION | 7 | $143 |
Products named: TREMFYA, OPZELURA, Zoryve, DUPIXENT, OTEZLA, Bimzelx, RINVOQ, SKYRIZI.
Industry payments across CA — which companies pay providers there.
